Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramVP, Corporate ControllerCIK 0002095702
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 27 | Bulis Veronica SanchezVP, Corporate Controller |  LYELLyell Immunopharma, Inc.Open-market sale | SELL | $8,905 621 sh | Aug 11, 2026 traded Aug 10, 2026 | |
Bulis Veronica SanchezVP, Corporate Controller |
| LYELLyell Immunopharma, Inc. Open-market sale |
| SELL |
| $4,103 217 sh |
| Jun 15, 2026 traded May 11, 2026 |
| 27 | Bulis Veronica SanchezVP, Corporate Controller | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $5,872 254 sh | Feb 11, 2026 traded Feb 10, 2026 |
| 17 | Bulis Veronica SanchezVP, Corporate Controller | LYELLyell Immunopharma, Inc. Grant or award | A | — 8,750 sh | Feb 11, 2026 traded Feb 10, 2026 |
| 31 | Bulis Veronica SanchezVP, Corporate Controller | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $44K 1,136 sh | Jan 6, 2026 traded Dec 24, 2025 |
| 27 | Bulis Veronica SanchezVP, Corporate Controller | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $30K 936 sh | Jan 6, 2026 traded Dec 30, 2025 |
| 31 | Bulis Veronica SanchezVP, Corporate Controller | LYELLyell Immunopharma, Inc. Open-market sale | SELL | $3,848 239 sh | Nov 12, 2025 traded Nov 10, 2025 |